Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. - Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; et al. (Nature, 2016)